NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹3.00 Cr | ₹0.40 Cr | ₹15 Cr | ₹8.00 Cr | ₹1.20 Cr |
What is the latest Contingent Liabilities ratio of NATCO PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹3.00 Cr |
| Mar2024 | ₹0.40 Cr |
| Mar2023 | ₹15 Cr |
| Mar2022 | ₹8.00 Cr |
| Mar2021 | ₹1.20 Cr |
How is Contingent Liabilities of NATCO PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.00 Cr | 650.00 | |
| Mar2024 | ₹0.40 Cr | -97.26 | |
| Mar2023 | ₹15 Cr | 82.50 | |
| Mar2022 | ₹8.00 Cr | 566.67 | |
| Mar2021 | ₹1.20 Cr | - | |
Compare Contingent Liabilities of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹14,847.4 Cr | -1.6% | -9.1% | -3.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -1.6% |
-9.1% |
-3.1% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses